SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-22-099269
Filing Date
2022-09-12
Accepted
2022-09-12 16:35:16
Documents
1
Group Members
BETA OPERATORS FUND, L.P.PARAG SAXENAVEDANTA ASSOCIATES, L.P.VEDANTA ASSOCIATES-R, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2225524d2_sc13da.htm SC 13D/A 127440
  Complete submission text file 0001104659-22-099269.txt   129218
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 212-710-5220
VEDANTA PARTNERS, LLC (Filed by) CIK: 0001502216 (see all company filings)

IRS No.: 261741447 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90624 | Film No.: 221238954
SIC: 2834 Pharmaceutical Preparations